Hope and Reality

When discussing prognosis and treatment options with older leukemia patients, should the focus be on the 10 percent who will survive long-term or the 90 percent who won’t? By trying to prepare patients, do doctors risk dashing their hopes? Mikkael Sekeres, MD, MS, Director of Cleveland Clinic’s Leukemia Program, mulls those difficult questions in his New York Times column.